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ABSTRACT
Processive transcription antitermination requires
the assembly of the complete antitermination
complex, which is initiated by the formation of the
ternary NusB–NusE–BoxA RNA complex. We have
elucidated the crystal structure of this complex,
demonstrating that the BoxA RNA is composed
of 8nt that are recognized by the NusB–NusE
heterodimer. Functional biologic and biophysical
data support the structural observations and estab-
lish the relative significance of key protein–protein
and protein–RNA interactions. Further crystallo-
graphic investigation of a NusB–NusE–dsRNA
complex reveals a heretofore unobserved dsRNA
binding site contiguous with the BoxA binding site.
We propose that the observed dsRNA represents
BoxB RNA, as both single-stranded BoxA and
double-stranded BoxB components are present in
the classical lambda antitermination site. Combin-
ing these data with known interactions amongst
antitermination factors suggests a specific model
for the assembly of the complete antitermination
complex.
INTRODUCTION
Processive transcription antitermination, a system best
characterized in bacteriophage lambda ( ), involves hi-
jacking and structural modiﬁcation of host RNA polymer-
ase (RNAP) by a complex of proteins and RNA, enabling
the regulation of transcription through downstream ter-
mination sites. During lytic infection, phage   utilizes this
process to control the timing of transcription of particular
genes essential for lytic growth as the virus switches from
early, to delayed-early, to late gene expression (1). Many
other viruses, including the HIV provirus, use analogous
systems of transcription control through the use of RNA
regulatory elements (2).
The   antitermination complex consists of phage N
protein, N-utilization (nut) RNA control sequences
BoxA and BoxB, and host proteins referred to as
N-utilization substances A, B, E and G (NusA, NusB,
NusE and NusG). NusE is also known as ribosomal
protein S10 of the 30S ribosome subunit (3). As such,
this protein exhibits moonlighting behavior by playing
roles in distinct complexes involved in transcription or
translation in a mutually exclusive manner (4,5). BoxA
and BoxB facilitate antitermination through several
protein–RNA interactions. BoxA binds to the host
NusB–NusE heterodimer (6,7) and the BoxB stem loop
binds to the N protein (8–11). A spacer region, to which
NusA binds (12), separates these two RNA segments.
Although less well understood, a similar mechanism is
employed by the bacterial host in the transcription
control of ribosomal RNA operons (rrn) using the same
Nus factors, other ribosomal proteins, a host-encoded
BoxA RNA and a BoxB-like RNA (reviewed in 13).
The   antitermination complex assembly likely begins
with the association of NusB with BoxA as its sequence is
transcribed. This is in concert with the formation of
the NusB–NusE heterodimer, which facilitates and
strengthens the binding to other transcription elongation
components including N protein, BoxB, NusA, NusG and
RNAP (14). Association of NusB, NusE and BoxA is
therefore a regulatory event during the initial assembly
of the complete antitermination complex (4,15), and has
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tion. Moreover, the NusB–NusE heterodimer has been
shown to bind BoxA with greater afﬁnity than either
protein alone (7,16,17). The ribosome binding loop of
Escherichia coli (Ec) NusE/S10 was shown to be dispens-
able for   transcription antitermination by genetic replace-
ment of the loop with a serine (4). The crystal structure of
the EcNusB–NusE complex was thus solved and UV
cross-linking studies were used in an attempt to identify
the amino acids responsible for binding of BoxA RNAs
encoded in the Ec rrn operons (EcBoxA) (4). Those ex-
periments provided a general indication of the BoxA
binding region, but atomic details necessary to understand
the protein–RNA interactions are still lacking, and have
proven to be a major experimental hurdle. As an alterna-
tive approach, we used orthologous proteins from Aquifex
aeolicus (Aa). Although phylogenetically divergent, the
NusB and NusE proteins from these two bacteria are
similar, sharing amino acid sequence identities of 28 and
53%, respectively (Figure 1A and B). Furthermore, we
previously reported the solution structure of AaNusB
and demonstrated similar protein–protein interactions at
the NusB–NusE interface for the two bacterial systems
(18). In this study, we have also replaced the ribosome
binding loop of AaNusE with a single serine (Figure 1B)
to improve solubility and provide a more globular struc-
ture conducive for crystallization.
An Aa rrn BoxA (AaBoxA) was identiﬁed by sequence
comparison with Ec rrn operons, and a synthetic 12-mer
BoxA RNA (50-GGC UCC UUG GCA-30) was used in
crystallization experiments (Figure 1C). This particular
12-mer RNA exists as a stable duplex at room tempera-
ture, with a melting temperature of  32 C (see
Supplementary Data), and was therefore utilized as both
single-stranded BoxA and generic double-stranded (ds)
RNA by varying experimental temperatures. In this
work, we outline the detailed RNA interactions of
AaNusB–NusE with both BoxA and dsRNA, as well as
the structure–functional signiﬁcance of each. We also
demonstrate by NMR and biophysical measurements
that the AaNusB–BoxA interactions are equivalent in E.
coli. Lastly, our genetic complementation assays for
AaNusB in E. coli support the functional interpretation
of the new crystal structures and demonstrate
cross-species NusB–NusE–RNA interaction.
MATERIALS AND METHODS
Cloning, coexpression and puriﬁcation of AaNusB-NusE
AaNusB was prepared as described (18). To coexpress the
AaNusB–NusE complex, genes encoding AaNusE
(residues 47–68 replaced with a single Ser) and AaNusB
were cloned into suitable donor vectors, followed
by multi-site recombination into a tagless destination
vector (pDEST42) using Gateway cloning technology
(Invitrogen, Carlsbad, CA, USA). The proteins were
coexpressed in E. coli and soluble lysate was incubated
for 30min at 90 C and clariﬁed by centrifugation. The
sample was puriﬁed by ion-exchange chromatography.
Further details are provided in Supplementary Data.
Crystallization and structure determination
Crystals of AaNusB–NusE–BoxA were grown at 37 C.
Crystals of AaNusB–NusE–dsRNA were grown at room
temperature. All data were collected at the Advanced
Photon Source and processed with HKL 3000 (19).
Molecular replacements were performed using Phaser
(20). Model building and reﬁnement were carried out
using the programs COOT (21) and PHENIX (22), re-
spectively. All ﬁgures were generated using PyMol (23).
Data, reﬁnement statistics and other structural informa-
tion are summarized in Table 1. Further details are
provided in Supplementary Data.
EcNusB and EcBoxA preparations and biophysical
measurements
EcNusB proteins were cloned, expressed and puriﬁed
using the methods previously described (18,24). NMR
spectra were collected on Varian Inova spectrometers at
either 600 or 800MHz equipped with ChiliProbes.
Sequential backbone assignments were made using
standard triple resonance pulse sequences (25). Data
were processed and analyzed using NMRPipe (26) and
CCPNMR (27) and scripts therein. Sequential backbone
and side-chain assignments of the EcNusB-BoxA complex
were complete for  95% of the protein. Analytical
ultracentrifugation was performed at 25000rpm, 20 C,
using a Beckman XL-1 Optima analytical ultracentrifuge
(Beckman Coulter, Inc., Brea, CA, USA). The protein–
RNA interaction studies were performed using a
VP-ITC Microcalorimeter (MicroCal LLC, Northamp-
ton, MA, USA) at 25 or 35 C. The integrated heat-of-
interaction values were ﬁt using the Origin 7.0-based
ITC data analysis software (MicroCal). Further details
are provided in Supplementary Data.
Functional assay for AaNusB complementation in E. coli
The entire nusB ORF (open reading frame) was deleted
from the E. coli chromosome by recombineering as
described (28). The Ec W3110 DnusB cells were trans-
formed with plasmids expressing Aa or EcNusB proteins
or with naked pET vector as a control. The transformed
cells were then analyzed for cell growth at different tem-
peratures. To assay for the NusB requirement in the
growth of phage  , the DnusB cells containing the
AaNusB, EcNusB or control plasmids, were plated,
spotted with serial phage dilutions and incubated at
42 C to observe the formation of   plaques. Further
details are provided in Supplementary Data.
RESULTS
The NusB–NusE heterodimer recognizes 8nt of BoxA
Crystal data, reﬁnement and structural details are
provided in Table 1. Representative electron density is
shown in Figure 1D. The crystal structure of AaNusB–
NusE–BoxA contains two independent copies each of
AaNusB, AaNusE and AaBoxA in the form of a dimer
of ternary complexes (Supplementary Figure S1A), which
can be superimposed with a root-mean-square deviation
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light-scattering experiments demonstrate that the inter-
action between the two complexes is both concentration
and temperature dependent and that AaNusB–NusE is
monomeric under native conditions. The four protein
molecules are interconnected through two distinct
NusB–NusE interfaces: one biologically relevant and pre-
viously observed in solution (18) and the other induced by
dimerization. The data revealed electron density for eight
and 10 out of the 12nt for BoxA molecules R and S, re-
spectively, but the 10th nucleobase of chain S is buried
between symmetry-related AaNusB molecules in the
crystal lattice and its position is thus considered an
artifact of crystallization (Supplementary Figure S1C).
The AaBoxA RNA demonstrates extensive base-speciﬁc
interactions with protein, beginning at the N-terminal
Figure 1. Sequence and structure of NusB, NusE and rrn BoxA. (A and B) Structure-based sequence alignments of NusB and NusE from A. aeolicus
(Swiss-Prot codes: O66530, O66430) and E. coli (Swiss-Prot codes: P0A780, P0A7R5). Residues shaded in gray were removed by genetic manipu-
lation and replaced by a serine to form modiﬁed versions of EcNusE (4) and AaNusE (this work). (C) Sequence alignment of the rrn BoxA regions.
Nucleotides in red denote positions that are different in the E. coli sequence relative to that of A. aeolicus. (D) Stereo representation of AaBoxA
(chain R) as it exists in the crystal structure of AaNusB–NusE–BoxA, including electron density from a 2Fo Fc omit map contoured at 1s.
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NusE interface (Figure 2 and Supplementary Figure S2).
These contacts include both hydrogen bonds and hydro-
phobic interactions with bases of AaBoxA nucleotides
1–8. The AaBoxA–protein interface comprises at least
30 interactions with an average of 3–4 interactions per
nucleotide, but all protein–RNA interactions except
those involving AaBoxA-U8 are speciﬁc to AaNusB
alone (Figure 2B and C). The direct contribution to
AaBoxA binding by AaNusE is observed in the
AaBoxA-U8 nucleotide binding site formed by the
AaNusB–NusE protein–protein interface (Figure 2A and
C). Within this binding pocket, AaBoxA-U8 is held tightly
in place through hydrophobic stacking interactions with
both faces of the uracil ring, provided by AaNusB-F122
and AaNusE-R16. The guanidinium group of R16 also
donates a hydrogen bond directly to the 20-O of the
AaBoxA-U8 ribose. Aside from spatial constraints,
base-speciﬁcity of AaBoxA-U8 is achieved through two
hydrogen bonds: one, which exists between the
backbone NH of AaNusB-G78 and O4 of the uracil
base and the other between endocyclic N3 and AaNusB-
E81. AaNusE-H15 donates a hydrogen bond that is
bifurcated by the carboxylate oxygen atoms of
AaNusB-E81, thereby stabilizing the E81 side chain in a
conformation favorable for AaBoxA-U8 recognition.
Together, these contributions by AaNusE enhance
AaBoxA afﬁnity and speciﬁcity. AaNusB-K118 also
binds to this region of AaBoxA through ionic interaction
with the phosphate group of AaBoxA-G9 (Supplementary
Figure S2). However, information pertaining to the ribose
and nucleobase moieties of AaBoxA-G9 is inconclusive
due to crystallographic disorder as well as differences
between the two complexes of AaNusB–NusE–BoxA
observed in the crystal structure (Supplementary Figures
S1 and S2). NMR data of a complex of EcNusB and
EcBoxA also reveal interaction between EcBoxA nucleo-
tide 9 and amino acid residues near EcNusB-118, yet these
data do not reveal a single interacting conformation
(Supplementary Figure S3E). We believe, therefore, that
the relevant BoxA nucleotides do not extend beyond
position 8.
The NusB-NusE interface is conserved across
A. aeolicus and E. coli
The comparison between the crystal structures of
AaNusB–NusE–BoxA (this work) and EcNusB–NusE
(4) shows that the r.m.s.d. for the NusB components,
the NusE components and the NusB–NusE complexes
are 1.5, 0.8 and 1.7 A ˚ , respectively. The structures show
that 6 out of 11 NusB and all 10 NusE residues involved in
NusB–NusE heterodimer formation are conserved
between the two species, with buried surface areas of
1620 and 1626 A ˚ 2 for the Aa and Ec complexes, respect-
ively. The NusB–NusE interface is dominated by
hydrophobic interactions and assisted by additional elec-
trostatic interactions between the two proteins. Almost
all interactions can be complemented in a cross-species
NusB–NusE complex, indicating that the formation of
such a complex is possible. Our genetic complementation
experiments of AaNusB in E. coli show that an AaNusB–
EcNusE complex is indeed formed in vivo (vide infra).
NMR chemical-shift mapping reveals a similar
BoxA binding site for EcNusB
The BoxA binding site on EcNusB was determined using
NMR chemical-shift differences (d) between the free (29)
and EcBoxA-bound states of EcNusB (Figure 2D and
Supplementary Figure S3C). The d shift map reveals a
contiguous EcBoxA binding surface spanning part of helix
a6 (K101-E106), residues E117 and D118 in the loop
connecting helices a6 and a7, and most of helix a7
(S119-D128) (Figures 1A and 2D). The largest d are
observed near F122, which emphasizes the signiﬁcance
of this conserved amino acid for BoxA recognition.
Additionally, all amino acid residues in the EcNusB
Table 1. X-ray diffraction data and reﬁnement statistics
AaNusB–
NusE–BoxA
AaNusB–
NusE–dsRNA
Crystal
Space group P21 P212121
Unit cell parameters
a (A ˚ ) 40.5 76.8
b (A ˚ ) 113.0 79.9
c (A ˚ ) 65.8 106.6
  ( ) 102.9 90
Matthews coefﬁcient (A ˚ 3/Da) 2.4 2.6
Data Overall (last shell) Overall/(last shell)
Resolution (A ˚ ) 40.00–1.90 (1.97–1.90) 50.00–2.20 (2.28–2.20)
Unique reﬂections 42602 (3354) 32257 (3160)
Redundancy 5.0 (2.8) 5.7 (5.5)
Completeness (%) 94.2 (74.5) 94.7 (94.5)
Rmerge
a 0.102 (0.520) 0.057 (0.542)
I/s(I) 19.3 (1.7) 26.7 (3.1)
Reﬁnement
b Overall/(last shell) Overall/(last shell)
Resolution (A ˚ ) 35.67–1.90 (1.95–1.90) 33.64–2.20 (2.26–2.20)
Unique reﬂections 42498 (2150) 32201 (2634)
Completeness (%) 93.9 (71) 94.6 (94)
Data in the test set 2160 (98) 1659 (135)
Rwork 0.169 (0.258) 0.201 (0.273)
Rfree 0.202 (0.292) 0.239 (0.357)
Structure
Observed Electron Density
AaNusB (A) 1–138 0–69, 73–134
c
AaNusB (B) 1–137 0–137
c
AaNusE (J)
d 3–47, 69–102 4–47, 69–103
AaNusE (K)
d 3–47, 69–103 4–47, 69–103
AaBoxA (R) 1–9
e 1–12
f
AaBoxA (S) 1–10 5–12
Protein non-H atoms/B (A ˚ 2) 4066/32.9 3524/64.7
RNA non-H atoms/B (A ˚ 2) 432/37.7 375/88.4
Water oxygen atoms/B (A ˚ 2) 240/40.3 98/56.9
Other solvent atoms/B (A ˚ 2) 78/56.4 35/91.5
R.m.s.d.
Bond lengths (A ˚ ) 0.007 0.004
Bond angles ( ) 1.028 0.723
Coordinate error (A ˚ ) 0.23 0.33
Ramachandran plot
Favored regions (%) 99.3 99.0
Disallowed regions (%) 0.0 0.0
aRmerge=|(I <I>)|/(I), where I is the observed intensity.
bReﬁnements included the use of TLS parameters.
cAmino acid residue 0 is an additional methionine beyond the
N-terminal methionine of the sequence and is a cloning artifact.
dNusE residues 47–68 have been replaced by a serine as S47.
eNucleotide residue 9 contains atoms P, O1P, O2P and O5*, i.e. the
50-phosphate, only.
fNucleotide residue 3 has a zero occupancy.
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upon EcBoxA binding.
The orientation of EcBoxA on the EcNusB surface was
determined using d values obtained upon binding of
EcBoxA mutants U1C and A9C. EcNusB-D118N was
employed in these NMR experiments as this mutant
binds EcBoxA with higher afﬁnity in the absence of
EcNusE (30). In the D118N/BoxA-U1C spectrum, small
d ( 0.1ppm) are observed for residues L74, E81, K101,
N105, I134 and K139, with the largest d for K101 and
K139 (Supplementary Figure S3D). In the D118N/
BoxA-A9C spectrum, small d ( 0.1ppm) are observed
for I27, R72, E106, A116, D117 and N118 NH’s
(Supplementary Figure S3E). These data indicate that
the 30-end of EcBoxA is near the N-terminus of EcNusB
helix a6, with nucleotides 8 and 9 near the A116-D118
loop. The EcBoxA binding site on EcNusB, as well as
the orientation of EcBoxA on the EcNusB surface, is con-
sistent with the AaNusB–NusE–BoxA crystal structure
(Figure 2A and D).
Figure 2. The BoxA binding site is highly sequence-speciﬁc. (A) Surface representation in stereo of the AaNusB–NusE–BoxA ternary complex
illustrating all protein-BoxA interactions. AaNusB-contributing residues are shown in cyan and AaNusE residues in orange as ball-and-stick models.
AaBoxA nucleotide bases are color-coded by base type according to the schematic in panel B. (B) Schematic of interactions between AaBoxA and
AaNusB–NusE residues as observed in the crystal structure. Amino acid residues in bold are involved in nucleobase speciﬁcity. Asterisks denote
residues interacting with 20-OH groups of RNA. Residues labeled in red belong to AaNusE. The base of AaBoxA-G9 is shown with dotted lines to
indicate that it is disordered. (C) Details of AaBoxA-U8 interactions with AaNusB–NusE at the heterodimer interface. (D) Surface representation of
the chemical shift map of EcNusB upon binding of EcBoxA, presented on the solution structure of EcNusB (PDB ID: 1EY1) with EcBoxA (white)
positioned as in the AaNusB–NusE–BoxA structure. The residues are colored according to the magnitude of d (EcNusB subtracted from EcNusB–
BoxA) ranging from  0ppm (blue) to 1.2ppm (red) (Supplementary Figure S3C). Differences between the chemical-shift-mapped EcBoxA binding
site of EcNusB, relative to that observed in the Aa crystal structure, are primarily at the N-terminus. Residues A4-R8 (gray) are disordered in the
free EcNusB protein and thus no d could be calculated. However, the N-terminal resonances are observed in the EcNusB–BoxA complex,
suggesting that this region is stabilized by interactions with EcBoxA. Similarly, exchange-broadened residues S119-K121, also for which no d
could be calculated, are shown in gray.
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jN-mediated antitermination
NusB is involved in both cellular and phage  
functions in E. coli, being conditionally required for cell
growth at low temperatures and   growth at 42 C (31).
Therefore, EcDnusB cells possess a characteristic
cold-sensitive growth phenotype at temperatures below
30 C. Compared to wild-type (wt) Ec cells (nusB
+), the
EcDnusB cells grow slower at 37 C, but at a comparable
rate at 42 C. However, the EcDnusB cells do not support
formation of wt   ( 
+) plaques during phage infection at
42 C. These two functions of NusB can be efﬁciently
restored through trans-expression of wt EcNusB from a
plasmid and is the molecular basis for genetic comple-
mentation (28).
The BoxA binding site on NusB is a region of high
phylogenetic conservation, particularly along its
C-terminal a-helix (a7) (29). As seen in the AaNusB–
NusE–BoxA structure, the semi-exposed and conserved
aromatic residue in a7, NusB-F122, exhibits ring
stacking with the U8 nucleobase (Figure 2C). In order
to test its importance for NusB function, EcNusB-F122
was mutated to aspartic acid and analyzed in vivo for its
ability to complement EcDnusB cells in the support of
E. coli and phage   growth (Supplementary Table S1).
The EcnusB-F122D mutant is defective as compared
to EcnusB
+, which is demonstrated by its cold-sensitivity
and inability to promote   growth (Supplementary Table
S1). The mutant protein is correctly folded, as shown
by minimal differences between the NMR spectra
(Supplementary Figure S4A and B) and similar retention
times on a size exclusion column as wt EcNusB. The
wt EcNusB binds to EcBoxA in a 1:1 complex with a
Kd=2mM (Supplementary Table S2). However,
EcNusB-F122D did not detectably bind EcBoxA as
measured by either ITC or NMR when present in a 1:1
ratio. It remains to be determined how this single point
mutation, which would potentially result in a minimal
loss of protein–RNA interactions, can abolish binding
of BoxA. Nevertheless, it is the only known EcnusB
missense mutation resulting in defects in both cellular
and phage   antitermination activities. Two previously
known missense mutations, EcnusB5 (32) and EcnusB101
(33–35) show effects mostly in phage   antitermination
activities, and the effect of EcnusB101 is only observed
in conjunction with EcnusA or EcnusE mutations, being
otherwise neutral (33).
Complementation by AaNusB in E. coli is BoxA-sequence
dependent
The functional homology between the Aa and EcNusB
proteins has been assessed in a genetic complementation
assay using EcDnusB cells. Once again, the cellular and  
growth defects of the EcDnusB cells can be compensated
by the trans-expression of functional EcNusB from a
plasmid (28) (Figure 3A and B). Unlike cells transformed
with the control vector, cells transformed with the
EcNusB plasmid grow normally at 30 and 37 C. Under
the same growth conditions, the expression of AaNusB
from plasmid DNA also restores the growth of EcDnusB
cells at 30 and 37 C. AaNusB is therefore capable of com-
plementing EcNusB in the context of the protein’s cellular
functions, most likely through productive interactions
with EcBoxA and EcNusE during rRNA synthesis. This
interpretation was validated using ITC, which revealed
that EcBoxA binds to AaNusB (Supplementary Table S2).
Contrasting results for genetic complementation are
observed in the  -related activities of EcNusB. Here,
 nin5 (36) is used as a control, as it is known to form
plaques even in the absence of EcNusB (37). The  
+infec-
tion of EcDnusB cells expressing EcNusB from a plasmid
generates plaques, whereas, in cells expressing AaNusB
from a plasmid, no plaques are generated at 42 C
(Figure 3B). By contrast, AaNusB is capable of supporting
growth of a phage   mutant,  boxA9, whose BoxA is
identical to EcBoxA (Figure 3C), thus indicating that
the AaNusB complementation is BoxA-sequence
dependent.
The crystal structure of AaNusB–NusE–BoxA provides
a molecular basis for the differences observed for AaNusB
complementation of Ec cellular versus  N-mediated func-
tions. The rrn BoxA sequences of E. coli and A. aeolicus
differ at positions 1, 6 and 9 (Figure 3C). Structural
analysis suggests that two of these differences are likely
to be insigniﬁcant. A BoxA-C6U substitution would have
minimal effects on binding, as the interaction between O2
of the pyrimidine base with AaNusB-S128 would be
conserved (Supplementary Figure S2). A substitution
from N4 to O4 on the pyrimidine ring would result in
the loss of a hydrogen bond with phosphate O2 of
AaBoxA-C5, and require slight changes in atomic
position to avoid electrostatic repulsion between the two
oxygen atoms. Similarly, a BoxA-G9A substitution would
likely be tolerated, as this nucleotide is a purine in both
cases and AaBoxA-G9 exhibits no clear base-speciﬁc inter-
actions with NusB or NusE proteins. Therefore, the only
difference in the rrn BoxA sequences of E. coli and
A. aeolicus that would have structural implications for
binding is at position 1. As observed in the crystal struc-
ture, AaBoxA-G1 participates in several hydrogen bonds
with AaNusB that would be lost in the case of EcBoxA-U1
(Figure 2 and Supplementary Figure S2). Nevertheless, the
sum of these changes has very little effect on AaNusB
binding and function in E. coli (Figure 3A). The greater
differences between Aa and  BoxA sequences have greater
structural implications, by which the latter is incapable
of binding to AaNusB (Supplementary Table S2).
Once again, a BoxA-C6U substitution would likely have
little or no effect (vide supra). However, a transversion
substitution, BoxA-G1C, when accompanied by two
other transversion substitutions, BoxA-U8A and G9C
(Figure 3C), would lead to the disruption of several
hydrogen bonds, resulting in signiﬁcantly reduced
binding energy between  BoxA and the AaNusB–
EcNusE complex. AaNusB residues in the BoxA-binding
site that are not conserved in EcNusB may cause further
disruption of RNA–protein interactions.
Taken together, the major structural difference at
position 1 of EcBoxA is tolerated by AaNusB–EcNusE
with respect to binding and cellular growth, whereas the
added differences at positions 8 and 9 of  BoxA are not
7808 Nucleic Acids Research, 2011,Vol.39, No. 17tolerated. How EcNusB–NusE tolerates the transversion
substitutions at positions 8 and 9 of  BoxA remains to
be established. However, previous studies have shown a
weaker EcNusB–NusE binding afﬁnity for  BoxA relative
to EcBoxA (15,17,30), most likely caused by forcing a
bulkier adenine base into the EcBoxA-U8 binding
pocket shaped by the EcNusB–NusE interface. This is
further supported by the fact that the EcBoxA- and
 BoxA binding afﬁnities for NusB alone are virtually
the same (Supplementary Table S2). Hence, the absence
of the binding pocket results in less nucleotide
discrimination.
Structural bases for observed mutant phenotypes
Previous studies have identiﬁed mutations in both
EcNusB and EcNusE, as well as mutations in  BoxA
Figure 3. Complementation by AaNusB in E. coli is BoxA-sequence dependent. (A) Growth complementation assay of EcDnusB cells with NusB
expressed from plasmid DNA. The EcDnusB cells were transformed with plasmids expressing EcNusB (pAB47), AaNusB (pKM772) or with the
control pET vector. The growth of transformants was measured by incubating cells on L medium containing 50mg/ml ampicillin at 30 C for 2 days,
or at 37 or 42 C for 1day (Supplementary Table S1). (B) Plaque assays demonstrating the complementation of nusB-deﬁcient   growth by trans-
expression of Ec or AaNusB from plasmid DNA. By contrast to phage  
+,  nin5 does not require NusB for phage growth and was thus used as a
positive control for plaque formation. A mutant derivative of  ,  boxA9, has three base changes that create a BoxA RNA that is identical
to EcBoxA. It gains the ability to plaque and illustrates that complementation by AaNusB is dependent on speciﬁc NusB-BoxA interactions.
(C) Comparison of BoxA RNA sequences for Aa, Ec,  
+ and  boxA9. Nucleotides in underlined boldface indicate differences in BoxA sequences
relative to that of AaBoxA. (D) Other   derivatives with boxA mutations that affect  N-dependent antitermination activity (indicated in underlined
boldface) and their reported Kd values (30). Plaquing ability of   carrying these mutations is shown. The+ +indicates the enhanced ability to make
plaques by the A8U mutant (52).
Nucleic Acids Research, 2011,Vol.39, No. 17 7809that affect the efﬁciency of antitermination. Two of these
mutants, EcnusB5 (32) and EcnusE100 (38), whose single
point mutations were identiﬁed as EcNusB-Y18D (35)
and EcNusE-R72G, respectively, likely result in the dis-
ruption of the EcNusB–NusE heterodimer, as both of
these amino acid side chains are buried deep within the
protein–protein interface (4,18). The distant location of
these residues in relation to the BoxA binding site
suggests that they have little effect on BoxA binding
(Figure 4A). Indeed, EcNusB-Y18D maintains EcBoxA-
binding afﬁnity relative to wt EcNusB and is otherwise
a folded, monomeric protein (Supplementary Table S2
and Supplementary Figure S4C).
The structural bases for EcNusB-D118N and
EcNusE-A86D phenotypes (35), caused respectively by
the EcnusB101 (33–35) and EcnusE71 (3) mutations, are
much less obvious. EcNusB-D118N and EcNusB-D118K
(30) are compensatory mutants that rescue   growth
defects induced by a mutation in EcNusA (EcnusA1),
most likely by enhancing  BoxA afﬁnity for
EcNusB-NusE via interaction with asparagine or lysine
side chains, which is not possible in the case of the
native aspartic acid. Indeed, the crystal structure of
AaNusB–NusE–BoxA, which naturally contains a lysine
at AaNusB position 118, exhibits contacts between
AaNusB-K118 and AaBoxA-G9. Likewise, modeling of
AaNusB-K118N reveals favorable interaction potential
between the asparagine side chain and the phosphate
group of AaBoxA-G9 (Figure 4A and B).
By contrast, the addition of these few interactions
provided by lysine or asparagine at this position, do not
signiﬁcantly improve binding to EcBoxA. Previous in vitro
studies using ﬂuorescence anisotropy titrations showed
that the EcNusB-D118N and D118K mutants have
enhanced EcNusB–NusE binding afﬁnity for  BoxA but
not for EcBoxA (30). Further supporting evidence is
provided by experiments with  imm21 (35), whose BoxA
RNA is identical to EcBoxA, demonstrating that
EcNusB-D118N rescues the growth of phage  , but not
 imm21, in E. coli cells carrying the nusA1 mutation. We
propose, therefore, that the selective binding enhancement
of the EcNusB-D118K and D118N mutants for  BoxA
results from the transversion substitutions at positions
8 and 9 (Figure 3C), in which the additional inter-
actions with BoxA generated by these rescue mutations
are of greater impact in the case of  BoxA and are
required to rescue phage growth. However, further
structural investigation of RNA–protein interactions is
necessary, particularly for  BoxA, in order to support
this claim.
Figure 4. Structural bases for EcNusB and EcNusE mutant phenotypes. (A) Stereoscopic view shows the Ca-trace superposition of EcNusB–NusE
(PDB ID: 3D3B, in magenta) and AaNusB–NusE–BoxA (this work, in cyan). Also shown are BoxA as a cartoon (colored as in Figure 2) and side
chains of amino acid residues whose mutational effects have been previously reported, as ball-and-sticks. (B and C) Structural bases for the
EcnusB101 and EcnusE71 mutants through side-chain modeling. The AaNusB–NusE–BoxA (this work), EcNusB–NusE (PDB ID: 3D3B), and
EcNusB101–NusE (PDB ID: 3IMQ) structures are superimposed. For AaNusB–NusE–BoxA, polypeptide backbones are shown as cartoons
(helices as spirals, strands as arrows and loops as tubes) in blue, and nucleotides and amino acid side chains as ball-and-sticks in atomic colors
(N in blue, O in red, P in orange, C of RNA in yellow and C of protein in cyan). For EcNusB–NusE and EcNusB101–NusE, polypeptide backbones
are not shown for clarity and amino acid side chains are shown as ball-and-sticks but C in magenta. Modeled amino acid side chains are shown as
ball-and-sticks but C in white. Potential interactions are shown as dashed lines in black.
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the heterodimer interface and the BoxA binding site
(Figure 4A), most likely plays another role. An aspartate
in this position can be modeled within hydrogen-bonding
distance of a conserved arginine (NusE–R31) that is
solvent exposed (Figure 4C). In the structure of
AaNusB–NusE–BoxA, NusE–R31 forms crystal contacts
with the second copy of AaNusB. This may indicate that
EcNusE-R31 is involved in the binding of another protein
in the antitermination complex, possibly RNAP (39), and
that its interaction with EcNusE-A86D may weaken or
preclude its native function. The introduction of a
negative charge at this position may also directly disrupt
interactions electrostatically. However, EcNusE-A86D,
which inhibits growth of  
+, does not inhibit growth of
 imm21 or Ec host cells (35). This suggests that any
negative impact posed by EcNusE-A86D is compensated
by the greater BoxA afﬁnities in the  imm21 and E. coli
cellular antitermination systems. Whereas, in the case of
 
+, EcNusE-A86D necessitates a compensatory mutation
(EcnusB101, EcNusB-D118N) in order to achieve the
required  BoxA afﬁnity.
Several phenotypes resulting from mutations in  BoxA
have also been observed (Figure 3D). The mutation,
 BoxA-A8U (39), actually enhances  N-mediated
antitermination. Indeed, BoxA-U8, present in both Aa
and EcBoxA sequences, binds tightly in the pocket
formed by the NusB–NusE interface in the crystal
structure of AaNusB–NusE–BoxA, and exhibits key
base-speciﬁc interactions that are likely to be absent in
the case of adenine (Figure 2C). Other mutations in
 BoxA, including G2U, C5A and U6G, inhibit
 N-mediated antitermination and have greatly reduced
afﬁnity for the EcNusB–NusE heterodimer (30), suggest-
ing that transversion substitutions are not tolerated at
 BoxA positions 2, 5 or 6 (Figure 3D). It is also evident
from the crystal structure of AaNusB–NusE–BoxA that
these conserved nucleotides, G2, C5 and C6 (AaBoxA)
or G2, C5 and U6 (Ec and  BoxA), play signiﬁcant
roles in both cellular and  N-mediated antitermination
activities, due to their extensive and speciﬁc inter-
actions with NusB residues (Figure 2 and Supplementary
Figure S2).
The AaNusB-NusE heterodimer forms a contiguous
binding site for dsRNA
As aforementioned, the 12-mer RNA used in crystalliza-
tion experiments forms a stable duplex at temperatures
below 32 C. Room-temperature crystallization of the
A. aeolicus ternary complex (Supplementary Figure S5)
led to the discovery of a novel binding site for dsRNA,
which is generated by the surface of the NusB–NusE
heterodimer (Figure 5A), and is positioned directly
adjacent to the BoxA binding site (details in Discussion).
Although not as numerous as the interactions with BoxA,
the strength of dsRNA binding by NusB–NusE is
achieved through several electrostatic interactions
between dsRNA backbone atoms and positively-charged
protein side chains. The structure reveals six residues
of AaNusB (K5, K36, N37, K39, N40 and K113) and
four residues of AaNusE (K9, R11, R45 and K46) that
contribute to the binding of dsRNA. As virtually all
protein-dsRNA contacts are limited to the RNA
backbone, the mode of binding is primarily sequence-
independent (Figure 5A), with the exception of AaNusE-
R45, which has additional interactions with a base
pair. The four AaNusE residues are conserved in E. coli
(Figure 1) and at least three out of the four (R11, R45 and
K46) contribute to NusE/S10-dsRNA interaction within
the 30S ribosome subunit (PDB codes 2AVY and 3KIQ).
Some of the dsRNA-binding residues of NusB, on the
other hand, demonstrate weaker conservation, particular-
ly D39, D42 and S113 (EcNusB). This may indicate a
smaller, yet still relevant, contribution of EcNusB in the
binding of dsRNA by EcNusB–NusE. Our NMR experi-
ments indicate that EcNusB–dsRNA interaction is more
dependent on the high-afﬁnity interaction with EcBoxA
(Supplementary Figure S6).
DISCUSSION
The phenomena of transcription termination and anti-
termination are best characterized in the  N-mediated
system (40–42). Hence, the discussion will be focused on
the  N-mediated transcription antitermination (For a dis-
cussion on other systems, see Supplementary Data). The
 N protein, whose interaction with RNAP is facilitated by
host proteins (NusA, NusB, NusE and NusG), binds to
the  nut site in the nascent RNA (43). How  N assists
RNAP to read through terminators remains unclear
(44), but its site of action appears to be in proximity to
the RNA:DNA hybrid of the transcription elongation
complex (45). As mentioned previously, the assembly of
the complete antitermination complex is required for
processive antitermination and begins with the formation
of the NusB–NusE–BoxA complex.
We have determined the crystal structure of the
NusB–NusE–BoxA ternary complex from A. aeolicus,
indentifying key protein–RNA interactions at atomic
resolution. The equivalence of the EcBoxA and AaBoxA
binding sites enables detailed interpretation of these
ﬁndings with respect to the biologic functions of the
NusB and NusE proteins. The structure shows that the
BoxA sequence comprises 8nt. The extensive interaction
between NusB and BoxA illustrates not only the strength
of binding energy (Supplementary Table S2), but also the
signiﬁcance of nucleotide-sequence speciﬁcity. The direct
contribution of NusE to the binding of BoxA is limited,
suggesting that the importance of NusE in the initiation of
transcription antitermination is demonstrated by add-
itional interactions with other antitermination complex
components.
The NusB–NusE complex binds an additional RNA
component not previously observed. We have shown
that a binding site for dsRNA is generated by the forma-
tion of the NusB–NusE heterodimer, which is contiguous
with the 50-end of the BoxA binding site (Figure 5B and
C). The binding of dsRNA involves primarily RNA-
backbone interactions, indicating that this dsRNA
binding site is independent of sequence, provided that
Nucleic Acids Research, 2011,Vol.39, No. 17 7811canonical A-form RNA secondary structure is main-
tained. Nonetheless, some sequence speciﬁcity may be
imposed by the conserved NusE-R45 to discriminate
generic dsRNA species from the physiological ligand of
the NusB–NusE heterodimer.
The only deﬁned dsRNA component involved in
 N-mediated antitermination, particularly within proxim-
ity to BoxA, is the stem-loop structure formed by BoxB
(Figure 6A). We propose, therefore, that the dsRNA
observed in these crystal structures may provide an
accurate representation of the BoxB stem-loop and that
NusB and NusE cooperatively form contiguous binding
surfaces for both BoxA and BoxB components (Figures
5C and 6B). As previously discussed, the conserved NusE
residues demonstrate similar dsRNA interactions within
the ribosome. Thus, the dual functionality of NusE may
involve, not only protein–protein interactions, but also
conserved protein-dsRNA interactions: with rRNA in
translation, with BoxB in antitermination.
It is known that the BoxB stem loop binds to phage  N
protein (8–11). To address the implications of this model
in the   system, the complexes presented in this work were
structurally aligned with an NMR structure of the BoxB
stem-loop bound to the N-terminal a-helix of  N protein
(PDB ID: 1QFQ) (11). The BoxB structure aligns with
the dsRNA observed in this work with near precision,
and positions the  N a-helix within close proximity
to AaNusE without steric clash (Figure 6B). Previous
studies have shown that the presence of NusB and NusE
increases the efﬁciency of a  N-like protein (Nun) to
modify transcription elongation (46), which, by this
model, would result from the formation of a stable
NusB–NusE–BoxA–BoxB complex that enables more
effective recruitment of  N/Nun protein.
It is indicated that NusG promotes anchoring of a
subcomplex, which we suggest to include NusB, NusE,
BoxA, BoxB and  N protein (Figure 6C, left), to RNAP
through its interactions with NusE (5). Superposition of
previous structures of NusG (47) and the NusE–NusG
complex (5), with the combined crystal structures pre-
sented in this work, is shown in Figure 6B. Association
of NusA with RNAP (48–50) aids in the recruitment of the
Figure 5. Binding of dsRNA by the NusB–NusE heterodimer. AaNusB molecules are colored in blue, AaNusE molecules in wheat and dsRNA in
magenta. Orientations in all panels are identical to that in Figure 2A. (A) Crystal structure of the AaNusB–NusE–dsRNA ternary complex in stereo.
Residues involved in dsRNA binding are depicted as ball-and-sticks with white surface. (B and C) Superposition of the crystal structures of AaNusB–
NusE–BoxA and AaNusB–NusE–dsRNA, illustrating the contiguous binding regions for AaBoxA and dsRNA. In panel C, the protein surface
representation is colored by vacuum-electrostatic potential (red, negative; blue, positive), which depicts the AaBoxA and dsRNA binding sites as a
contiguous positively-charged surface.
7812 Nucleic Acids Research, 2011,Vol.39, No. 17subcomplex through NusA interactions with  N protein
(51) and the  nut spacer RNA (12), which is located
between BoxA and BoxB. Together, the network of inter-
actions implies a highly compact quaternary structure
for the complete antitermination complex (Figure 6C,
right). These ﬁndings demonstrate the complexity of
structural interplay among various components of the
antitermination machinery, and provide a framework for
studying the underlying molecular mechanisms.
ACCESSION NUMBERS
The coordinates and structure factors for the AaNusB-
NusE–BoxA and AaNusB–NusE–dsRNA complexes
have been deposited in the Protein Data Bank as PDB
entries 3R2C and 3R2D. The sequential backbone
and side-chain assignments of the EcNusB–BoxA
complex have been deposited in the Biological Magnetic
Resonance Bank as BMRB entry 17526.
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